General Materials
All DNA constructs were verified by DNA sequencing, which was performed by The Sequencing Service, School of Life Sciences, University of Dundee, using DYEnamic ET terminator chemistry (Amersham Biosciences) on Applied Biosystems automated DNA sequencers. DNA for bacterial protein expression was transformed into E. coli BL21 DE3 RIL (codon plus) cells (Stratagene). All cDNA plasmids, antibodies and recombinant proteins employed in this study are available to request through our reagents website (https://mrcppureagents.dundee.ac.uk/).
General Methods
LC--MS was carried out with an Agilent 1200 LC--MS system fitted with a Max--Light Missed cleavage was observed at Lys63.
Preparation of Ub--1--45--SR
The plasmid pTXB1--Ub--1--45 was prepared by PCR deletion of the bases coding for resides 46--76 in the plasmid pTXB1--Ub--1--76 [1] by PCR. Deletion was confirmed by DNA
sequencing. pTXB1--Ub--1--45 was transformed into ER2566 cells (New England Biolabs) and
Ub--1--45--SR was expressed and purified as previously described for full--length ubiquitin [1] .
Peptides UbC46--76 and UbC46--76--pSer45
N--terminal cysteine peptides were sourced from Pepceuticals Ltd, UK on a 5 mg scale for UbC46--76 and a 25 mg scale for UbC46--76--pSer65. Requested purity level was >95%.
Expressed protein ligation
Ub residue thereby generating native Ub--pSer65. Removal of small molecule reaction components and folding was achieved by dialysis against folding buffer (10 mM Tris pH 7.5, 100 mM NaCl). Sample was subsequently passed through a desalting column.
In--gel trypic digestion and phospho mapping by LC--MS/MS
UbC46--pSer65 was reduced with DTT (5 mM) and boiled in 1X LDS sample buffer (Life spectrum was identified and which was then visualized in Xcalibur (Thermo Scientific).
Fragment masses were manually annotated as depicted in Figure S4 .
Parkin ubiquitylation assay
Wild--type Parkin (2 μg) was added to ubiquitylation assay component mastermix [50mM Tris/HCl (pH 7.5), 5 mM MgCl2, 0.12 μM ubiquitin E1, 1 μM UbcH7, 2 μg of His6-SUMO--Miro1 and 2 mM ATP]. Each reaction contained 0.05mM ubiquitin comprising 25 μg of FLAG--ubiquitin (Boston Biochem) mixed with 5 μg of Ub, Ub--pSer65, UbC46 or UbC46--pSer65. Ubiquitylation reactions were carried out as previously described [2] . Ubiquitylation reactions were subjected to analysis by immunoblotting as follows: ubiquitin (anti--FLAG antibody), Parkin (anti--Parkin antibody) and Miro--1 (anti--SUMO1 antibody). UbC46--pSer65
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